BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

89.420 -

+0.540 (+0.61%)
价格区间 88.750 - 90.740   (2.24%)
开盘 89.780
昨收 88.880
买 -
买盘 -
卖 -
卖盘 -
成交量 618,096
成交额 45,277,685
注释 -
数据延迟。最后一次更新02 Apr 2026 08:15.
数据提供商
查看所有活动

Loading Chart...

Please login to view stock data and analysis